Skip to main content
Log in

Neonatal transient respiratory depression after maternal urapidil infusion for hypertension

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Urapidil is a potent antihypertensive drug that has been in clinical use for more than 20 years. It has been proven to be an effective and well-tolerated antihypertensive drug during pregnancy, but clinical experiences with urapidil have been described in only a limited number of studies. There have also been only limited observations on the (side-)effects of urapidil on the neonate. We describe here a case of postnatal transient respiratory depression following maternal administration of urapidil. We suggest that the fetal and neonatal effects of more recently implemented antihypertensive drugs, such as urapidil, should be included in a prospective evaluation of antihypertensive treatment of women during pregnancy. Infants of mothers who received urapidil should be carefully watched in the immediate postnatal phase as urapidil may still exert some significant effects on the neonate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Curran A, Leiter J (2007) Baroreceptor-mediated inhibition after peripheral and central administration of a 5-HT1A receptor agonist in piglets. Exp Physiol 92:757–767

    Article  PubMed  CAS  Google Scholar 

  2. Gillis R, Hill K, Kirby J, Quest J, Hamosh P, Norman P, Kellar K (1989) Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exper Toxicol 248:851–857

    CAS  Google Scholar 

  3. Goda Y (1993) Ventilatory mechanical analysis of respiratory depression induced by serotonin. Hokkaido Igaku Zasshi 68:29–41

    PubMed  CAS  Google Scholar 

  4. Hanff L, Visser W, Vulto A, Steegers A (2006) Pharmacological treatment of severe pre-eclampsia. Eur Clinics Obstet Gynaecol 2:9–17

    Article  Google Scholar 

  5. König J, Meier-Dörzenbach E, Menge H, Müller H, Padberg G, Petersen-Knoche C, Schäfer H (1977) Toxicology study in the antihypertensive agent urapidil. Arzneimittelforschung 27:1919–1932

    PubMed  Google Scholar 

  6. Schulz M, Wacker J, Bastert G (2001) Effect of urapidil in antihypertensive therapy of preclampsia on newborns. Zentralbl Gynakol 123:529–533

    Article  PubMed  CAS  Google Scholar 

  7. Wacker J, Müller J, Unkels R, Bastert G (1994) Antihypertensive therapie bei schwangerschaftsinduzierter hypertonie (SIH) mit urapidil. Zentralalbl Gynäkol 116:271–273

    CAS  Google Scholar 

  8. Wacker J, Wagner B, Briese V, Schauf B, Heilmann L, Bartz C, Hopp H (2006) Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil. Eur J Obstet Gynecol Reprod Biol 127:160–165

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophie Vanhaesebrouck.

Additional information

The authors declare that there is no external funding source.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanhaesebrouck, S., Hanssens, M. & Allegaert, K. Neonatal transient respiratory depression after maternal urapidil infusion for hypertension. Eur J Pediatr 168, 221–223 (2009). https://doi.org/10.1007/s00431-008-0728-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-008-0728-8

Keywords

Navigation